References
- Bartlett J. G., Moon N. E., Goldstein P. R., Goren B., Onderdonk A. B., Polk B. F. Cervical and vaginal bacterial flora: ecologic niches in the female genital tract. American Journal of Obstetrics and Gynecology 1978; 130: 658–661
- Lyerly D. M., Sullivan N. M., Wilkins T. D. Enzyme‐linked immunosorbent assay for Clostridium difficile toxin A. Journal of Clinical Microbiology 1983; 17: 72–78
- Odds F. C. Problems in the laboratory assessment of antifungal activity. Postgraduate Medical Journal 1979; 55: 677–680
- Osterholm Davis J. P., Gibson R. W., Forfang C., Stolz S., Vergerant J. M., The Investigate Team. Toxic shock syndrome: relation to catamenial products, personal health hygiene and sexual practices. Annals of Internal Medicine 1982; 96: 954–958, Part II
- Ross W. S. Today's contraceptives: What's new? What's Best?. Readers Digest November, 1983; 217
- Stottmcier K. D., Woodley C. L., Kubica G. P. New approach for the evaluation of antimycobacterial drug combinations ‘in vitro’ (the laboratory model man). Applied Microbiology 1969; 18: 399–403
- VLI Corporation. TodayTM Vaginal contraceptive sponge: a technical review. 1983, June 1983